News - India, Biotechnology

Filter

Current filters:

IndiaBiotechnology

Popular Filters

Helperby Therapeutics and Cadila make progress on first antibiotic resistance breaker

Helperby Therapeutics and Cadila make progress on first antibiotic resistance breaker

19-06-2014

Helperby Therapeutics, a spin-out drug discovery company from St George’s University of London, UK,…

Antibiotic resistanceAntibioticsAntibiotics and Infectious diseasesBiotechnologyCadila PharmaceuticalsHelperby TherapeuticsIndiaUK

Bristol-Myers Squibb extends research accord with Biocon unit Syngene

Bristol-Myers Squibb extends research accord with Biocon unit Syngene

05-06-2014

US pharma major Bristol-Myers Squibb and Syngene International, India’s largest contract research organization,…

BioconBiotechnologyBristol-Myers SquibbIndiaResearchSyngene

India encouraging opportunities for biotech innovation

India encouraging opportunities for biotech innovation

27-05-2014

In a bid to encourage new and innovative ideas for research and commercialization, the Indian government's…

BiosimilarsBiotechnologyFinancialIndiaResearch

India’s bio-pharma market forecast to reach $7 billion by FY2015

08-05-2014

Growing at an average rate of about 20%, India’s biotech industry comprising bio-pharmaceuticals, bio-services,…

BiotechnologyIndiaMarkets & MarketingPatentsResearch

Boehringer Ingelheim launches diabetes collaboration with Connexios Life Sciences

Boehringer Ingelheim launches diabetes collaboration with Connexios Life Sciences

06-05-2014

German family-owned drug major Boehringer Ingelheim has announced a global research collaboration with…

BiotechnologyBoehringer IngelheimDiabetesGermanyHealth Medical PharmaHealth Medical PharmaIndiaIngelheim am RheinLicensingMajorResearch

Aurigene and Pierre Fabre announce licensing agreement for novel immunotherapy

Aurigene and Pierre Fabre announce licensing agreement for novel immunotherapy

13-02-2014

Privately-owned Pierre Fabre and Aurigene, a leading Indian biotech company, have entered into an agreement…

Aurigene DiscoveryBiotechnologyFranceIndiaLicensingOncologyPierre Fabre

Gilead to offer hep C drug sofosbuvir at greatly-reduced price in developing countries

Gilead to offer hep C drug sofosbuvir at greatly-reduced price in developing countries

07-02-2014

US biotech Gilead Sciences has indicated it would charge $2,000 per 24 week treatment course for the…

Anti-viralsBiotechnologyGilead SciencesGlobalIndiaPricingsofosbuvirSovaldi

Mylan gets exclusive rights to distribute Gilead branded drugs in India

Mylan gets exclusive rights to distribute Gilead branded drugs in India

31-01-2014

US generics major Mylan says its India-based subsidiary has been named) exclusive branded medicines business…

AmbisomeAnti-viralsAsia-PacificBiotechnologyGilead SciencesIndiaMarkets & MarketingMylan LaboratoriesStribildTruvadaViread

Back to top